Early clinical predictors of intractable epilepsy in childhood

Semra Saygi1, İlknur Erol, Füsun Alehan

  • 1Department of Pediatrics, Başkent University, Ankara, Turkey. semra_saygi@yahoo.com

Insights

Identifying intractable epilepsy in children is possible early on. High daily seizure frequency and remote symptomatic causes are key predictors, guiding better treatment strategies.

Area of Science:

  • Pediatric Neurology
  • Epileptology

Background:

  • Antiepileptic drug (AED) therapy is a cornerstone in managing pediatric epilepsy.
  • Intractable epilepsy poses significant challenges in treatment and patient management.

Purpose of the Study:

  • To evaluate clinical responses to AED therapy in pediatric epilepsy patients.
  • To identify risk factors associated with the development of intractable epilepsy in children.

Main Methods:

  • Retrospective study analyzing data from a single treatment center.
  • Inclusion of 28 children with intractable epilepsy and 213 with drug-responsive epilepsy.
  • Univariate and multivariate logistic regression analyses were performed.

Main Results:

  • Significant risk factors for intractable epilepsy included age at onset, high daily seizure frequency, infantile spasms, neonatal seizures, abnormal neurodevelopment, neurological abnormalities, mental retardation, remote symptomatic etiology, and abnormal brain imaging.
  • High daily initial seizure frequency and remote symptomatic etiology were identified as independent predictors of intractable epilepsy.

Conclusions:

  • The early clinical course of childhood epilepsy can help predict the risk of developing intractable forms.
  • Early identification of high-risk patients can optimize therapeutic interventions and minimize ineffective treatments.
Abstract

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.7K
Epilepsy ll: Types01:22

Epilepsy ll: Types

Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.
1
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
2.4K
Seizures l: Introduction01:20

Seizures l: Introduction

Understanding seizures and epilepsy relies on key definitions that help in recognizing, classifying, and managing these disorders. These definitions provide a framework for recognizing, classifying, and managing seizure disorders.DefinitionsA seizure is a sudden, abnormal burst of electrical activity in the brain that can cause changes in awareness, movement, sensation, or behavior, depending on the area involved. Epilepsy is a chronic condition characterized by recurrent, unprovoked seizures,...
2
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
1.2K